Caroline Copley
Caroline Copley
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Germany targets doctors, border states in vaccination drive

Germany targets doctors, border states in vaccination drive

By , BERLIN (Reuters) - Germany will supply general practitioners with vaccines and deliver additional doses to regions on the Czech and French borders as it seeks to get its campaign back on track following a three-day pause in using the AstraZeneca shot.“The motto is ‘vaccinate, vaccinate, vaccinate’,” German Chancellor Angela Merkel said after a meeting with the leaders of Germany’s 16 federal states.Case numbers have been rising in Germany, driven by an easing of restrictions in recent weeks just as a more transmissible variant of the virus has spread, underlining the need to accelerate...

March 19, 2021
Share
Save
Review
No Rating
Merkel to take control from German states in pandemic battle

Merkel to take control from German states in pandemic battle

People queue outside a coronavirus disease (COVID-19) test site at a city's shopping zone, during pandemic lockdown, in Berlin, Germany, March 31, 2021. REUTERS/Fabrizio BenschRegister now for FREE unlimited access to Reuters.comBERLIN, April 9 (Reuters) - German Chancellor Angela Merkel plans to take control from federal states to impose restrictions on regions with high numbers of new coronavirus infections, a government spokeswoman said, in a battle to curb a third wave of the pandemic.The federal government plans to introduce draft legislation next week, she said.Finance Minister Olaf...

April 9, 2021
Share
Save
Review
No Rating
Germany decides AstraZeneca COVID shot can be used for over-60s, document shows

Germany decides AstraZeneca COVID shot can be used for over-60s, document shows

By , BERLIN (Reuters) - German federal and state health ministries agreed that from Wednesday AstraZeneca’s COVID-19 vaccine can be used for people aged 60 and above, following further reports of a rare brain blood disorder, a document on their agreement showed.Acting on advice from Germany’s vaccine committee, known as STIKO, the ministries also agreed the Anglo-Swedish firm’s vaccine could be used for high-risk patients aged below 60 as well as for high-priority groups such as medical workers.People aged below 60 who have already received a first AstraZeneca shot have the option of either...

March 30, 2021
Share
Save
Review
No Rating
Germany decides AstraZeneca COVID shot can be used for over-60s, document shows

Germany decides AstraZeneca COVID shot can be used for over-60s, document shows

By , BERLIN (Reuters) - German federal and state health ministries agreed that from Wednesday AstraZeneca’s COVID-19 vaccine can be used for people aged 60 and above, following further reports of a rare brain blood disorder, a document on their agreement showed.Acting on advice from Germany’s vaccine committee, known as STIKO, the ministries also agreed the Anglo-Swedish firm’s vaccine could be used for high-risk patients aged below 60 as well as for high-priority groups such as medical workers.People aged below 60 who have already received a first AstraZeneca shot have the option of either...

March 30, 2021
Share
Save
Review
No Rating
U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

By , SINGAPORE (Reuters) - AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once again, into controversy.The surprise public rebuke from federal health officials comes just one day after interim data from the drugmaker showed better-than-expected results from the U.S. trial. That had been seen as a scientific counter to concerns that have dogged the shot over its effectiveness and...

March 23, 2021
Share
Save
Review
No Rating
U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

By , SINGAPORE (Reuters) - AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once again, into controversy.The surprise public rebuke from federal health officials comes just one day after interim data from the drugmaker showed better-than-expected results from the U.S. trial. That had been seen as a scientific counter to concerns that have dogged the shot over its effectiveness and...

March 23, 2021
Share
Save
Review
No Rating
Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions

Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions

By , AMSTERDAM (Reuters) - Global health experts came under increasing pressure on Tuesday to clear up questions over the safety of AstraZeneca’s COVID-19 shot, as Sweden and Latvia joined countries suspending their use in a further blow to Europe’s vaccination rollout.The European Medicines Agency (EMA) said it was investigating reports of 30 cases of unusual blood disorders out of 5 million recipients of the AstraZeneca vaccine. In total, 45 million COVID shots have been delivered across the region.The EU regulator will release its findings on Thursday but its head, Emer Cooke, said she...

March 16, 2021
Share
Save
Review
  • Total 7 items
  • 1
OUTLETS
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
80%